Back to search
FDAFDA · Food and drugs·Recall number D-0943-2017

Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540

Published July 12, 2017 · Recall initiated: June 16, 2017

Summary

FDA records drug Class III recall D-0943-2017, published July 12, 2017 and initiated June 16, 2017. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 38,234 bottles; Lot: Lot #: a) GR3831, GS9690, Exp. 08/2019; b) GR3832, Exp. 08/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination With Other Product: Imipramine

What to do

Voluntary: Firm initiated · Letter

Get an email if AMITRIPTYLINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMITRIPTYLINE HYDROCHLORIDE
Manufacturer
Sandoz Incorporated
Distributor
Product was distributed throughout the United States
Lot
Lot #: a) GR3831, GS9690, Exp. 08/2019; b) GR3832, Exp. 08/2019.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540 recalled?

Yes. FDA published recall D-0943-2017 on July 12, 2017. Reported hazard: Cross Contamination With Other Product: Imipramine

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMITRIPTYLINE HYDROCHLORIDE.